{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:37:16Z","timestamp":1790303836201,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.antiviral.2006.01.009","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T12:09:13Z","timestamp":1139918953000},"page":"105-111","source":"Crossref","is-referenced-by-count":23,"title":["Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference"],"prefix":"10.1016","volume":"70","author":[{"given":"Momoko","family":"Otaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonao","family":"Sada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Nagano-Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2006.01.009_bib1","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.clinthera.2004.11.002","article-title":"Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis","volume":"26","author":"Anlar","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.antiviral.2006.01.009_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.virusres.2004.01.012","article-title":"Control of nonsegmented negative-strand RNA virus replication by siRNA","volume":"102","author":"Barik","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2006.01.009_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/35053110","article-title":"Role for a bidentate ribonuclease in the initiation step of RNA interference","volume":"409","author":"Bernstein","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2006.01.009_bib4","doi-asserted-by":"crossref","first-page":"11539","DOI":"10.1073\/pnas.0504926102","article-title":"Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain","volume":"102","author":"Bharali","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2006.01.009_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","article-title":"Inhibition of respiratory viruses by nasally administered siRNA","volume":"11","author":"Bitko","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2006.01.009_bib6","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1128\/JVI.77.21.11531-11535.2003","article-title":"Human immunodeficiency virus type 1 escape from RNA interference","volume":"77","author":"Boden","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib7","doi-asserted-by":"crossref","first-page":"9225","DOI":"10.1128\/JVI.76.18.9225-9231.2002","article-title":"Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference","volume":"76","author":"Coburn","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib8","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","article-title":"Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition","volume":"78","author":"Das","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2006.01.009_bib10","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1093\/emboj\/20.23.6877","article-title":"Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate","volume":"20","author":"Elbashir","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2006.01.009_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/088307380301801201","article-title":"Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study","volume":"18","author":"Gascon","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nature00873","article-title":"Short interfering RNA confers intracellular antiviral immunity in human cells","volume":"418","author":"Gitlin","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2006.01.009_bib13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/JVI.79.2.1027-1035.2005","article-title":"Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches","volume":"79","author":"Gitlin","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.286.5441.950","article-title":"A species of small antisense RNA in posttranscriptional gene silencing in plants","volume":"286","author":"Hamilton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2006.01.009_bib15","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/AAC.48.12.4631-4635.2004","article-title":"Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis","volume":"48","author":"Hosoya","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.01.009_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2005.10.001","article-title":"Inhibition of drug-resistant HIV-1 by RNA interference","volume":"69","author":"Huelsmann","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.01.009_bib17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1128\/JCM.40.5.1733-1738.2002","article-title":"Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups","volume":"40","author":"Itoh","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature00896","article-title":"Modulation of HIV-1 replication by RNA interference","volume":"418","author":"Jacque","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2006.01.009_bib19","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/JCM.35.10.2651-2653.1997","article-title":"Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan","volume":"35","author":"Katayama","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt940","article-title":"Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase","volume":"22","author":"Kim","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/JVI.64.2.700-705.1990","article-title":"Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus","volume":"64","author":"Kobune","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib22","series-title":"Field's Virology","first-page":"1305","article-title":"Paramyxoviridae: the viruses and their replication","author":"Lamb","year":"2001"},{"key":"10.1016\/j.antiviral.2006.01.009_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nbt0502-500","article-title":"Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells","volume":"20","author":"Lee","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib24","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/JVI.79.3.1645-1654.2005","article-title":"Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape","volume":"79","author":"Leonard","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/418038a","article-title":"RNA interference in adult mice","volume":"418","author":"McCaffrey","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2006.01.009_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nbt0502-497","article-title":"U6 promoter-driven siRNAs with four uridine 3\u20323overhangs efficiently suppress targeted gene expression in mammalian cells","volume":"20","author":"Miyagishi","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ije\/18.3.684","article-title":"Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan","volume":"18","author":"Okuno","year":"1989","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib28","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1128\/JVI.75.9.4399-4401.2001","article-title":"Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor","volume":"75","author":"Ono","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib29","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.antiviral.2006.01.009_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nbt0502-505","article-title":"Effective expression of small interfering RNA in human cells","volume":"20","author":"Paul","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2003.08.005","article-title":"Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism","volume":"61","author":"Phipps","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.01.009_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virol.2004.02.021","article-title":"RNA interference as a new strategy against viral hepatitis","volume":"323","author":"Radhakrishnan","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2006.01.009_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2004.01.011","article-title":"Interfering with hepatitis C virus RNA replication","volume":"102","author":"Randall","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2006.01.009_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng1117","article-title":"A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference","volume":"33","author":"Rubinson","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2006.01.009_bib35","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1099\/0022-1317-75-12-3511","article-title":"Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures","volume":"75","author":"Shibahara","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib36","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1038","article-title":"Activation of the interferon system by short-interfering RNAs","volume":"5","author":"Sledz","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib37","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1099\/0022-1317-80-4-879","article-title":"The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon","volume":"80","author":"Song","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1099\/vir.0.19513-0","article-title":"Hepatitis C virus NS5A protein interacts with 2\u2032,5\u2032-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner","volume":"85","author":"Taguchi","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/095632020401500201","article-title":"Gene silencing of HIV-1 by RNA interference","volume":"15","author":"Takaku","year":"2004","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2006.01.009_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1348-0421.2004.tb03556.x","article-title":"Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome","volume":"48","author":"Takigawa","year":"2004","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib41","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1128\/JVI.78.14.7523-7527.2004","article-title":"Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib42","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1128\/JVI.79.11.7050-7058.2005","article-title":"Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region","volume":"79","author":"Wilson","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2004.09.005","article-title":"Inhibition of SARS-CoV replication by siRNA","volume":"65","author":"Wu","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.01.009_bib44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nbt739","article-title":"siRNA-mediated gene silencing in vitro and in vivo","volume":"20","author":"Xia","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2006.01.009_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(00)80620-0","article-title":"RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals","volume":"101","author":"Zamore","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2006.01.009_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nm1174","article-title":"Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat. Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206000295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206000295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T17:11:52Z","timestamp":1586711512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354206000295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0166354206000295"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2006.01.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}